Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 4, Avril 2012
Page(s) 381 - 387
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012284015
Publié en ligne 25 avril 2012
  1. Aylon Y, Oren M. New plays in the p53 theater. Curr Opin Genet Dev 2011 ; 21 : 86–92. [CrossRef] [PubMed]
  2. Belyi VA, Ak P, Markert E, et al. The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2010 ; 2 : a001198. [CrossRef] [PubMed]
  3. Khoury MP, Bourdon JC. p53 Isoforms: an intracellular microprocessor? Genes Cancer 2011 ; 2 : 453–465. [CrossRef] [PubMed]
  4. Meyer G. p73: a complex gene for building a complex brain. Cell Cycle 2011 ; 10 : 1188–1189. [CrossRef] [PubMed]
  5. Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011 ; 18 : 1487–1499. [CrossRef] [PubMed]
  6. Rinne T, Brunner HG, van Bokhoven H. p63-associated disorders. Cell Cycle 2007 ; 6 : 262–268. [CrossRef] [PubMed]
  7. Rostagno P, Wolchinsky Z, Vigano AM, et al. Embryonic stem cells as an ectodermal cellular model of human p63-related dysplasia syndromes. Biochem Biophys Res Commun 2010 ; 395 : 131–135. [CrossRef] [PubMed]
  8. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999 ; 398 : 708–713. [CrossRef] [PubMed]
  9. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999 ; 398 : 714–718. [CrossRef] [PubMed]
  10. Gambaro K, Aberdam E, Virolle T, et al. BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ 2006 ; 13 : 1075–1087. [CrossRef] [PubMed]
  11. Medawar A, Virolle T, Rostagno P, et al. DeltaNp63 is essential for epidermal commitment of embryonic stem cells. PLoS One 2008 ; 3 : e3441. [CrossRef] [PubMed]
  12. Aberdam E, Barak E, Rouleau M, et al. A pure population of ectodermal cells derived from human embryonic stem cells. Stem Cells 2008 ; 26 : 440–444. [CrossRef] [PubMed]
  13. Shalom-Feuerstein R, Lena AM, Zhou H, et al. ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011 ; 18 : 887–896. [CrossRef] [PubMed]
  14. Lo Iacono N, Mantero S, Chiarelli A, et al. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development 2008 ; 135 : 1377–1388. [CrossRef] [PubMed]
  15. Rouleau M, Medawar A, Hamon A, et al. TAp63 is important for cardiac differentiation of embryonic stem cells and heart development. Stem Cells 2011 ; 29 : 1672–1683. [CrossRef] [PubMed]
  16. Su X, Paris M, Gi YJ, et al. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 2009 ; 5 : 64–75. [CrossRef] [PubMed]
  17. Rouleau M, Pucéat M, Aberdam D. Fonction inattendue de p63 dans le développement cardiaque : un phénotype peut en cacher un autre. Med Sci (Paris) 2011 ; 27 : 905–909. [CrossRef] [EDP Sciences] [PubMed]
  18. Gressner O, Schilling T, Lorenz K, et al. TAp63 induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005 ; 24 : 2458–2471. [CrossRef] [PubMed]
  19. Petitjean A, Cavard C, Shi H, et al. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene 2005 : 24 : 512–519. [CrossRef] [PubMed]
  20. Petitjean A, Ruptier C, Tribollet V, et al. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis 2008 ; 29 : 273–281. [CrossRef] [PubMed]
  21. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002 ; 416 : 560–564. [CrossRef] [PubMed]
  22. Wu G, Osada M, Guo Z, et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res 2005 ; 65 : 758–766. [PubMed]
  23. Suh EK, Yang A, Kettenbach A, et al. p63 protects the female germ line during meiotic arrest. Nature 2006 ; 444 : 624–628. [CrossRef] [PubMed]
  24. Gonfloni S, Di Tella L, Caldarola S, et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 2009 ; 15 : 1179–1185. [CrossRef] [PubMed]
  25. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci USA 2011 ; 108 : 3624–3629. [CrossRef]
  26. Truong AB, Kretz M, Ridky TW, et al. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006 ; 20 : 3185–3197. [CrossRef] [PubMed]
  27. Senoo M, Pinto F, Crum CP, McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007 ; 129 : 523–536. [CrossRef] [PubMed]
  28. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005 ; 437 : 275–280. [CrossRef] [PubMed]
  29. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, et al. miR-203 represses stemness by repressing DeltaNp63. Cell Death Differ 2008 ; 15 : 1187–1195. [CrossRef] [PubMed]
  30. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing stemness. Nature 2008 ; 452 : 225–229. [CrossRef] [PubMed]
  31. Carroll DK, Brugge JS, Attardi LD. p63, cell adhesion and survival. Cell Cycle 2007 ; 6 : 255–261. [CrossRef] [PubMed]
  32. Graziano V, De Laurenzi V. Role of p63 in cancer development. Biochim Biophys Acta 2011 : 1816 : 57–66. [PubMed]
  33. Ruptier C, De Gaspéris A, Ansieau S, et al. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression. Oncogene 2011 ; 30 : 4656–4665. [CrossRef] [PubMed]
  34. Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000 ; 87 : 368–372. [CrossRef] [PubMed]
  35. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, et al. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 2009 ; 15 : 6284–6291. [CrossRef] [PubMed]
  36. Flores ER, Sengupta S, Miller JB, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005 ; 7 : 363–373. [CrossRef] [PubMed]
  37. Keyes WM, Vogel H, Koster MI, et al. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc Natl Acad Sci USA 2006 ; 103 : 8435–8440. [CrossRef]
  38. Su X, Chakravarti D, Cho MS, et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 2010 ; 467 : 986–990. [CrossRef] [PubMed]
  39. Caron de Fromentel C, Maguer-Satta V. Quand les mutants de p53 se livrent à des trafics ! Med Sci (Paris) 2010 ; 26 : 814–816. [CrossRef] [EDP Sciences] [PubMed]
  40. Ansieau S, Caron de Fromentel C, Bastid J, et al. Role of the epithelial-mesenchymal transition during tumor progression. Bull Cancer 2010 ; 97 : 7–15. [PubMed]
  41. Herfs M, Hubert P, Suarez-Carmona M, et al. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. Am J Pathol 2010 ; 176 : 1941–1949. [CrossRef] [PubMed]
  42. Adorno M, Cordenonsi M, Montagner M, et al. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 2009 ; 137 : 87–98. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.